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Introduction

Coronavirus disease (COVID-19) is an emerging and rapidly evolving public health issue that
has become globally widespread and an overwhelming pandemic. Clinical manifestations of
the disease include asymptomatic carrier states, acute respiratory distress syndrome, and
even multiorgan dysfunction. Here, we present a unique and rare case of an acute ischemic
stroke (AIS) in an asymptomatic pregnant woman with no predisposing medical illnesses.
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Discussion

An 18-year-old G2P1 African American woman at 7 weeks gestational age with no significant
medical or family history presenting to the Emergency Department during the initial phases
of the pandemic with complaints of new onset left arm and left leg weakness with National
Institute of Health Stroke Scale (NIHSS) of 10. Computed tomography of the brain showed
an acutely evolving ischemic infarction in the right middle cerebral artery territory. Other
etiologies for causes of her ischemic stroke were ruled out through supporting laboratory testing. Since she did not present early enough due to concerns about the Coronavirus
pandemic, tissue plasminogen activator was not administered. COVID-19 was suspected,
confirmed and deemed the likely explanation of the cause of her acute ischemic large-vessel
stroke. The patient was treated with aspirin and clopidogrel daily and showed significant
improvement of her left-sided weakness. She eventually regained her ability to walk and was
still pregnant at the time of follow-up.
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Conclusions

COVID-19 can be difficult to diagnose since the presentation can vary widely and initial presentation may range from asymptomatic carrier states such as in our patient. In this case,
we explain how we reached a diagnosis of AIS likely secondary to COVID-19 and provide
further discussion regarding the neurological manifestations and treatment in pregnancy.
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Introduction

The Coronavirus disease 2019 (COVID-19) is a
global pandemic that has affected more than
48 million people, caused over 1.2 million deaths
worldwide and is increasing daily.1 Over the
past few months, researchers, scientists and
clinicians have witnessed a myriad of different
clinical presentations of COVID-19, ranging
from asymptomatic carrier states to severe
acute respiratory distress syndrome. Although
COVID-19 has a predilection for the respiratory

system, several case reports have been published which show that the virus can also involve hematologic and neurological systems.2-4
In particular, we investigate the incidence of
large-vessel ischemic stroke in the young and
pregnant as a complication of the COVID-19
infection. We present a unique case of an acute
ischemic stroke (AIS) in an asymptomatic
pregnant woman with no predisposing medical
illnesses.
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Figure 1. A) Computed tomography (CT) of the brain without contrast showing ill-defined low-attenuation in the right frontal temporal lobe and associated basal ganglion with hyperdense right
middle cerebral artery. B) A repeat CT of the brain without contrast 2 months later showing a
chronic right frontal MCA distribution cortical infarct.

Clinical Findings

An 18-year-old pregnant African American
woman (G2P1001) with no significant medical history besides migraine headaches presented to the Emergency Department (ED)
during the initial phases of the pandemic with
complaints of new-onset left arm and left leg
weakness. The patient stated that she initially woke up around noon three days prior
to initial presentation with complaints of left
face, arm and leg numbness. At that time, she
also had a right-sided headache that lasted
all day and was still persistent at the time of
admission. She stated that she normally has
migraine attacks without associated weakness
or numbness but reported inability to ambulate
with this new episode. Shortly prior to this,
the United States declared a national state of
emergency in response to the COVID-19 pandemic. Several states enacted stay-at-home
orders to mitigate the spread of SARS-CoV-2,
the virus that causes COVID-19, to reduce the
burden on the U.S. healthcare system. For this
reason, the patient did not want to visit an obstetrician for prenatal care, which also delayed
her from seeking earlier medical attention.1
However, the weakness was persistent and she
eventually arrived at the ED for further evaluation three days after her symptoms began.
Initial physical examination revealed left-sided
facial paralysis, asymmetrical smile and left
upper extremity weakness (3/5 strength). She
exhibited decreased bilateral yet symmetrical
reflexes. Her speech was intact without evidence of dysarthria or aphasia. On presenta-
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tion, National Institutes of Health Stroke Scale
(NIHSS) was noted to be 10 (scores range from
0 to 42, with higher numbers indicating greater
stroke severity). The patient was outside of the
tPA window; therefore, she was admitted to
the hospital without need for thrombolysis.
Upon further work-up, urine drug screen was
positive for ethanol of 0.021% and cannabinoids. Pelvic ultrasound showed single live
early intrauterine pregnancy at seven weeks of
gestation. A computed tomography (CT) of the
brain with appropriate shielding of the uterus
was obtained (Figure 1A) which was notable
for an acutely evolving ischemic infarction in
the right middle cerebral artery (MCA) territory with hyperdense middle cerebral artery.
Magnetic resonance imaging (MRI) of the brain
with contrast (Figure 2) confirmed the CT findings. Magnetic resonance angiography (MRA)
of the head showed near complete occlusion
of the right MCA and its branches starting 7.5
mm from its origin. MRA of the neck, magnetic
resonance venogram (MRV) of the head, MRI
of the cervical spine and bilateral lower extremity duplex were all negative. A 2-Dimensional
Echocardiogram showed no patent foramen
ovale. Complete blood count and coagulation
panel were both within normal range. Fibrinogen level was 409 mg/dL (Normal: 291-538 mg/
dL) and D-dimer was 1.11 µg/L (Normal: 0.32
– 1.29 µg/L), both within normal limits for 2nd
trimester pregnancies. Hypercoagulable studies were ordered (Table 1) and negative. Our
patient was diagnosed with an acute ischemic
stroke (AIS) of the right middle cerebral artery
region. She was discharged from the hospital
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Figure 2. T2-FLAIR weight cerebral Magnetic Resonance image (MRI) of the brain without contrast, axial sections showing an incomplete right MCA flow void. There is a large middle right
MCA distribution region of hyperintense diffusion signal.
to an acute rehabilitation facility on aspirin 81
mg daily and clopidogrel 75 mg daily. She was
instructed to continue both medications for
the entire duration of her pregnancy and to
discontinue aspirin after delivery. A decision
to avoid statin was made per maternal-fetal
medicine given that the patient was in her
first trimester and its use is contraindicated in
pregnancy.
The patient followed up with the Graduate
Medical Education Continuity Clinic after
discharge. A repeat CT of the brain without
contrast (Figure 1B) showed a chronic right
frontal MCA distribution cortical infarct. Since
there was no apparent recognizable etiology
for her stroke, a SARS-CoV-2 Antibody IgG test
was ordered at that time, which was noted
to be positive (Reference range: negative). A
nasopharyngeal swab to detect current infection was not ordered at that time since the
patient did not exhibit the classical symptoms
of COVID-19, and it was also not ordered during
her hospitalization since testing was not readily available for asymptomatic patients. The
patient showed significant improvement with
outpatient physical therapy, regained some
motor function in her left upper extremity and
was still pregnant at the time of follow-up.

Discussion

The annual incidence of AIS in young African
American women less than 35 years of age is
approximately 20.7 out of every 100,000 cases.
However, the incidence of pregnancy-related
strokes in the same demographic is 52.5 out of
every 100,000 deliveries. Approximately 10% of

all strokes are associated with pregnancy, with
40% occurring during the antepartum period
and 50% of those occurring postpartum.5-7
Evidence states that healthy pregnant women
have both an increased generation of thrombin and fibrinogen and a decreased production
of protein S, leading to prothrombotic state.
Therefore, they are at an increased risk of intravascular inflammation and thrombosis during
pregnancy. This hypercoagulable physiologic
condition can be exaggerated in the setting of
infection, genetic mutations or autoimmune
conditions.8-10 In fact, recent studies from The
International Society of Thrombosis and Haemostasis has generated a simple algorithm for
the management of COVID-19 coagulopathy
with recommendations to administer low-molecular-weight heparin in pregnant women with
COVID-19 to prevent thrombotic complications
with COVID in pregnant patients. In addition,
since our patient had a history of migraines
with aura, this also increases of risk of stroke
15- to 17-fold, even without the synergistic effect of COVID-19.11
Given that our patient developed a large-vessel AIS during the antepartum period at seven
weeks gestation, it suggests that there may
have been a synergistic factor, not explained
by pregnancy alone, that contributed to her
unusual presentation.
Since our patient had no significant risk factors
for ischemic stroke besides pregnancy, she was
worked up for secondary causes. Autoimmune
diseases, genetic mutations and blood disorders were all considered but resulted negative
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Table 1. Negative Hypercoagulable Labs
Factor V Leiden Mutation
Antithrombin III Antigen
Free Protein S Antigen
Protein S Antigen
Protein C Antigen
Protein C Activity
APC Resistance
Lupus Anticoagulant aPTT
Dilute Russell Viper Venom
Factor II Mutation
JAK2 Mutation (PCR)
JAK2 Exon 12 Background
HIV 1 & 2 Ag/Ab 4th Gen
Anti-phospholipid antibody
Antinuclear Antibody
c-ANCA
Proteinase 3 (PR3)
p-ANCA
Atypical p-ANCA
Myeloperoxidase Antibody
Beta-2-GPI IgG Antibody
Beta-2-GPI IgA Antibody
Beta-2-GPI IgM Antibody
Anti-Prothrombin IgG
Phosphatidylserine IgG
Phosphatidylserine IgM
Anti-Cardiolipin IgG Ab
Anti-Cardiolipin IgA Ab
Anti-Cardiolipin IgM Ab
upon further workup as seen in Table 1. With
the rising evidence of large-vessel thrombosis
in young adults with COVID-19,12 our patient
was screened with serologic IgG antibody
testing. Despite being asymptomatic, our
patient tested positive for SARS-CoV-2 IgG
antibodies and this was our likely explanation
as to the identifiable cause of her AIS diagnosis. Although the exact mechanism is still
unknown, several studies have noted the virus
induces cytokine production, which causes
a hypercoagulable state through changes in
lipid metabolism and platelet aggregation.
Consequently, these overall prothrombotic
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changes induce platelet instability and rupture
leading to AIS as a life-threatening complication of COVID-19.13-16 SARS-CoV-2 in pregnancy
can not only affect the host but also the fetus
leading to fetal demise and even preterm labor.
Luckily, our patient’s pregnancy was unaffected
despite her neurological sequelae.
This case also serves to highlight some of the
public health issues of the COVID-19 pandemic. Since social distancing, facial mask wearing
and hand hygiene became the new preventative
guidelines, patients who developed symptomatic conditions delayed seeking hospital-level
care leading to poorer clinical outcomes.1 If our
patient arrived promptly to the hospital when
her symptoms initially began, then she may
have been within the thrombolytic window
for administration of intravenous tPA. Since
pregnancy is not a contraindication for tPA, our
patient may have been a candidate for thrombolysis if she had presented to the hospital
sooner.17 Subsequently, treatment of her AIS
included combination antiplatelet therapy with
clopidogrel and aspirin, both of which have
been shown to reduce the risk of recurrent
stroke during the first three months. Although
statins are also used for the prevention of
recurrent strokes, they were not prescribed to
our patient given its contraindication in pregnancy. Consequently, our patient was safely
treated for an acute large-vessel stroke without
fetal complications and also showed meaningful clinical recovery with improvement of her
initial presenting symptoms.

Conclusion

COVID-19 can be difficult to diagnose since
the presentation can vary widely. COVID-19
has been shown to induce a prothrombotic
state in young adults leading to an increased
risk of acute ischemic stroke (AIS), which is
a life-threatening medical condition. After an
extensive work-up, we can conclude that the
cause of this patient’s large-vessel ischemic
stroke was most likely due to the COVID-19
infection. This case serves to highlight the
importance of attending prenatal care, seeking medical attention in a timely fashion and
detecting the SARS-CoV-2 virus in asymptomatic patients. These patients with neurological
symptoms may be presenting with signs of
COVID-19, which could lead to earlier medi-
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cal attention and better clinical outcomes for
patients.
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